ArticleClinical journal of the American Society of Nephrology : CJASN2026
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment.
Abstract read
In one paragraph
Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multimodal data-driven clustering analysis of heart failure patients identifies two distinct patterns of heart failure with preserved ejection fraction: Results from the PACIFIC-PRESERVED study.Nature communications · 2026Observational
- Dulaglutide Effect on Proteins Associated With CKD Progression.Kidney international reports · 2026Article
- Multiple circulating inflammatory proteins are associated with pathological lesions and kidney function decline in IgA nephropathy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Andrzej S KrolewskiResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0002-1705-2953
Jani K HaukkaFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.ORCID 0000-0001-5663-0923
Zaipul I Md DomResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0003-3503-7391
Viktor R CurovicSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0002-4270-6701
Chunyi WuInstitute of Gerontology, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0009-0000-1559-8322
Mario Luca MorieriResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0001-6864-0547
Katsuhito IharaResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0001-9554-3646
Sok Cin TyeResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0002-7286-1745
Hiroki KobayashiResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0002-9674-0374
Youngshin KeumResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0001-8591-9689
Sathishkumar BaskaranOlink Inc., Waltham, Massachusetts.
Stefan MutterFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.ORCID 0000-0002-8293-6982
Simone TheiladeSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0002-1151-8951
Eiichiro SatakeResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0002-9784-4423
Narges RashidiOlink Inc., Waltham, Massachusetts.
Valma HarjutsaloFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Tarunveer S AhluwaliaSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0002-7464-3354
Monika A NiewczasResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0003-2371-595
Fergus FlemingRenalytix, New York City, New York.ORCID 0000-0002-5276-6652
Marlon PragnellJDRF International, New York City, New York.ORCID 0000-0001-8976-3511
Robert G NelsonResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0001-7307-3786
Joseph V BonventreDepartment of Medicine, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-7144-386
Per-Henrik GroopFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.ORCID 0000-0003-4055-6954
Peter RossingSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID 0000-0002-1531-4294
Niina SandholmFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.ORCID 0000-0003-4322-6942
Andrzej GaleckiInstitute of Gerontology, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0003-1542-4001
Alessandro DoriaResearch Division, Joslin Diabetes Center, Boston, Massachusetts.ORCID 0000-0002-3830-4304
Funding
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI Alessandro Doria · 1986 to 2026
$50.5MTumor necrosis factor superfamily of ligands and receptors in progressive renal decline in diabetesR01DK041526 · NIDDK · JOSLIN DIABETES CENTER · PI KROLEWSKI, ANDRZEJ S · 1990 to 2018
$7.8MMechanisms of Ischemic Kidney Injury and RepairR01DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSEPH VINCENT BONVENTRE · 1987 to 2026
$6.2MDevelopment of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 DiabetesR01DK126799 · NIDDK · JOSLIN DIABETES CENTER · PI KROLEWSKI, ANDRZEJ S · 2021 to 2024
$2.7MSearch for biomarkers to measure progression of diabetic nephropathy in Type 1 diabetes; application of proteomics technologiesDP3DK112177 · NIDDK · JOSLIN DIABETES CENTER · PI GALECKI, ANDRZEJ T, KROLEWSKI, ANDRZEJ S · 2016 to 2016
$2.3MUnderstanding the role of the Complement Proteome in progressive Diabetic Kidney DiseaseR01DK123459 · NIDDK · JOSLIN DIABETES CENTER · PI NIEWCZAS, MONIKA ANNA · 2020 to 2024
$2.3MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095183 · HC · MINNEAPOLIS MEDICAL RESEARCH FDN, INC. · PI GRIMM, RICHARD H · 1999 to 2000
$1.9MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095181 · HC · CASE WESTERN RESERVE UNIVERSITY · PI THIBONNIER, MARC · 1999 to 2000
$1.8MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095184 · HC · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BIGGER, J T · 1999 to 2000
$1.7MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095182 · HC · WAKE FOREST UNIVERSITY · PI GOFF, DAVID C · 1999 to 2000
$1.6MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUS-N01HC95178N01HC095178 · HC · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BYINGTON, ROBERT · 1999 to 2006
$1.5MPREVENTION OF CARDIOVASCULAR DISEASE IN DIABETER MELLLITN01HC095180 · HC · UNIVERSITY OF WASHINGTON · PI PROBSTFIELD, JEFFREY · 1999 to 2000
$1.5MJuvenile Diabetes Research Foundation United States of America 3-SRA-2015-106-Q-R & 2-SRA-2019-832-5-BNHLBI NIH HHS N01 HC095178NHLBI NIH HHS N01 HC095179NHLBI NIH HHS N01 HC095180NHLBI NIH HHS N01 HC095181NHLBI NIH HHS N01 HC095182NHLBI NIH HHS N01 HC095183NHLBI NIH HHS N01 HC095184NHLBI NIH HHS N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, and IAA-Y1-HC-1010NHLBI NIH HHS Y01 HC001010NHLBI NIH HHS Y01 HC009035NIDDK NIH HHS DP3 DK112177NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK039773NIDDK NIH HHS R01 DK041526NIDDK NIH HHS R01 DK123459NIDDK NIH HHS R01 DK126799NIH HHS DK041526, DK112177 & DK126799NIH HHS DK072388NIH HHS P30 DK036836Novo Nordisk NNF14OC0013659 -PROTONNovo Nordisk Fonden NNF18OC0052457, READ-GENNovo Nordisk Fonden NNFOC0013659-PROTONWellcome Trust 220027
Abstract
PubMed holds no abstract for this paper.
Indexed as
diabetic kidney diseasediabetic nephropathyESKD
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.